Trial
NCT06480201
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Texas A&M University
Collaborators
National Institute of Mental Health (NIMH)
Condition
Healthy
Intervention
Ketamine
Why stopped
Paused while the study is transferred from Baylor College of Medicine to Texas A\&M University.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-23